Integrative Pathways to Health and Illness
Integrative Pathways to Health and Illness
批准号:
10559172
负责人:
CAROL D. RYFF
金额:
$718.46万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-07-25 至 2028-08-31
关键词:
AdultAgeAge DistributionAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaArchivesAttentionBaseline SurveysBehavioralBiologicalBiological AssayBiological MarkersBiologyCOVID-19 pandemicChronicClinical Trials Data Monitoring CommitteesCognitiveCommunitiesComplexCustomDataData CollectionData SetDementiaDiseaseDocumentationDropsEducational workshopElderlyEnsureEventFundingGene ExpressionGene Expression RegulationGenomicsHealthHealth SciencesImpaired cognitionIndividualInequalityInterventionKnowledgeLifeLinkLongitudinal StudiesMeasuresMetadataMethodologyMinorityModelingMonitorMorbidity - disease rateNeurobiologyNeurosciencesOutcomeParticipantPathway interactionsPersonal SatisfactionPersonsPhysiologyPoliticsPreventionPsychosocial Assessment and CarePsychosocial FactorPublicationsPublishingQuality ControlRecurrenceResearchResourcesRunningSample SizeSamplingStressSurveysTestingTimeTranslatingWorkaffective neuroscienceagedaging brainbasebiopsychosocialcaregivingcognitive functioncognitive testingcomputerizeddesigndiariesemotion regulationexperiencefollow-upgenomic datahealth inequalitieshealthy agingjournal articlemiddle agemortalityneurobiological mechanismperceived discriminationpreventprotective factorspsychologicpsychosocialpsychosocial resourcespublic health relevanceracial disparityrecruitresiliencesocialsociodemographic factorssociodemographicssocioeconomic disparitysocioeconomicsstatisticstoolvirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT – MIDUS OVERALL PLAN
The Midlife in the U.S. (MIDUS) national longitudinal study has been ongoing since 1995. MIDUS is the only
national study focused on midlife with a wide age expanse at baseline. MIDUS also has unusual depth in its
psychosocial, biomarker, genomic, and neuroscience assessments, thus permitting a focus on neurobiological
mechanisms and pathways through which sociodemographic and psychosocial factors influence morbidity and
mortality. This application aims to conduct a 2nd wave of data collection on the MIDUS Refresher sample
(MR2) as well as a 4th wave of data collection on the Core sample (M4), including all projects in both. Four
projects (Survey, Daily Diary, Biomarkers, Genomics) are part of this U19 competing continuation application,
which is linked with an Ancillary U01 application on Alzheimer’s Disease (AD) and Related Dementias (ADRD)
that will examine midlife precursurs to cognitive decline, emotion regulation, brain aging, and their interplay.
Much of that prior work is also longitudinal, although it now includes new ADRD neuroscience and biomarkers.
Overall, the proposed activities involve over 5,200 U.S. adults that will be supported by an Administrative Core
responsible for orchestrating cross-project data collection and delivering high-quality, well-documented data; a
BioCore that ensures quality control in biomarker data collection and offers guidance on use of biomarkers;
and a Statistics Core that provides workshops on multiple topics (modeling longitudinal change, using genomic
data, linking MIDUS to other datasets). Recurring scientific themes in the proposed science are health
inequalities and racial disparities examined with the rich biopsychosocial data available in MIDUS, including
wide-ranging assessments of stress exposures across multiple waves, thereby providing indicators of
cumulative adversity. MIDUS is also known for its comprehensive assessments of psychosocial and
behavioral protective factors, thereby advancing research on resilience in the face of challenge. Aging on a
changing historical stage is another key theme in MIDUS exemplified by a past focus on hardships of the
Great Recession, and going forward, a new parallel focus on hardships of the COVID-19 pandemic. In terms
of scientific engagement, MIDUS is the most frequently downloaded study at the National Archive of
Computerized Data on Aging (NACDA). Widespread usage from the scientific community (26,000+ public
users) has culminated in 1,617 publications covering 38 substantive domains. Underscoring the momentum
behind MIDUS, more than half of these products are journal articles published during the current funding cycle
(2016-present).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 2 -- MIDUS Daily Diary Project
-
批准号:10707327
-
项目类别:
-
资助金额:$75.1万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Project 3 -- MIDUS Biomarker Project
-
批准号:10559178
-
项目类别:
-
资助金额:$260.65万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Integrative Pathways to Health and Illness
-
批准号:9321972
-
项目类别:
-
资助金额:$650.56万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Core C -- Statistics Core
-
批准号:10707320
-
项目类别:
-
资助金额:$24.98万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Integrative Pathways to Health and Illness
-
批准号:10707314
-
项目类别:
-
资助金额:$678.37万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Project 1 -- MIDUS Survey Project
-
批准号:10707322
-
项目类别:
-
资助金额:$120.37万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Integrative Pathways to Health and Illness
-
批准号:9188963
-
项目类别:
-
资助金额:$647.79万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Project 4 -- MIDUS Genomics Project
-
批准号:10559179
-
项目类别:
-
资助金额:$59.68万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Core A -- Administrative Core
-
批准号:10559173
-
项目类别:
-
资助金额:$75.52万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Integrative Pathways to Health and Illness
-
批准号:10004314
-
项目类别:
-
资助金额:$11.92万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Core A -- Administrative Core
-
批准号:10707315
-
项目类别:
-
资助金额:$74.85万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Project 4 -- MIDUS Genomics Project
-
批准号:10707335
-
项目类别:
-
资助金额:$56.91万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Core C -- Statistics Core
-
批准号:10559175
-
项目类别:
-
资助金额:$29.14万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Integrative Pathways to Health and Illness
-
批准号:10621477
-
项目类别:
-
资助金额:$110.25万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Project 1 -- MIDUS Survey Project
-
批准号:10559176
-
项目类别:
-
资助金额:$163.05万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Project 3 -- MIDUS Biomarker Project
-
批准号:10707331
-
项目类别:
-
资助金额:$263.48万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Project 2 -- MIDUS Daily Diary Project
-
批准号:10559177
-
项目类别:
-
资助金额:$66.55万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Project 1 - Changes in Daily Stress and Well-Being
-
批准号:10621481
-
项目类别:
-
资助金额:$110.25万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Longitudinal Perspectives on Race and Health in MIDUS: Insights from Milwaukee
-
批准号:8814956
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2015
-
负责人:CAROL D. RYFF
-
依托单位:
Longitudinal Perspectives on Race and Health in MIDUS: Insights from Milwaukee
-
批准号:9134590
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2015
-
负责人:CAROL D. RYFF
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: